Your Search Results

      • Trusted Partner
        June 2016

        Eat to Beat Alzheimer's

        by Francie Healey

        Eat to Beat Alzheimer's offers a practical guide and an empowering tool to bring nourishing, healthful, and delicious food into the lives of people concerned about Alzheimer's and other cognitive problems. Almost 9 million people in the U.S. suffer from Alzheimer's and other forms of dementia, and the toll is rapidly increasing. This book will appeal to everyone concerned about dementia and memory loss in either themselves or a loved one.Recent research makes clear that the impact of aging on the brain can be reduced by simple diet and lifestyle modifications. The delicious food choices and easy-to-prepare recipes in this book are based on the latest findings showing that they can help slow the progression of Alzheimer's and other conditions like it, or prevent them entirely.Readers will gain the knowledge and tools to take charge of their health by incorporating tasty, healing foods into their diet. The information in this cookbook will be as relevant and useful 20 years from now as it is today. And the recipes will still be just as delicious.

      • Trusted Partner
        January 2019

        Alzheimer's Disease and Other Dementias, Second Edition

        by Sonja M. Lillrank, M.D. and Dana K. Cassell; Foreword by Pat Levitt, Ph.D., Vice President, Chief Scientific Officer, and Director, The Saban Research Institute; Director, USC Neuroscience Graduate Program

        Dementias are brain disorders that impair memory, thinking, behavior, and physical activity. Alzheimer's disease is the most common form, affecting 50 to 60 percent of dementia patients, and yet the exact cause of Alzheimer's and how best to detect it early remain unknown. Alzheimer's Disease and Other Dementias, Second Edition provides helpful clarification of this group of diseases and their specific types. It explains how to recognize the symptoms of dementia or Alzheimer's disease, how these disorders are diagnosed, the latest theories about their cause, and how they can be treated. Also covered are the outlook for future prevention and treatment and resources providing further information for those seeking help coping with dementia.

      • Trusted Partner
        September 2011

        Vergiss Alzheimer!

        Die Wahrheit über eine Krankheit, die keine ist

        by Stolze, Cornelia

      • Trusted Partner
        October 2020

        Untertags

        by Urs Faes

      • Trusted Partner
        March 2004

        Gedächtnisstörungen, Demenz, Alzheimer

        Vorbeugung, Diagnose, Behandlung Warnsignale erkennen, Risikofaktoren ausschalten Ein Ratgeber für Patienten und Angehörige

        by Neumann, Bernd; Dr. med. Schäfer, Ulrich

      • Trusted Partner
      • Trusted Partner
        August 2018

        Alzheimer kann man vorbeugen

        Was wir jetzt essen müssen, um unseren Kopf für später fit zu halten

        by Cuneo, Cinzia / Übersetzt von Krabbe, Wiebke

      • Trusted Partner
      • Trusted Partner
      • Trusted Partner
        January 2021

        How to understand a new disease

        Patrol report

        by Wang Liming

        This book sorts out major events in life sciences from November 2019 to October 2020. In the first part, the author focuses on the progress made by scientists, especially Chinese scientists, in the context of the new crown epidemic. Including how to discover the new coronavirus, treat new coronary pneumonia, vaccine research and other issues that readers are concerned about. In the second part, the author combed the progress in the field of life sciences in 2020, including cutting-edge scientific researches such as organ transplantation, Alzheimer's disease, and gene editing. This book is recommended by Han Qide and He Fan in a preface. It is suitable for party and government agencies, practitioners in the pharmaceutical industry, and readers who care about life sciences.

      • Trusted Partner
        Biography & True Stories
        November 2024

        Walking in the dark

        James Baldwin, my father and I

        by Douglas Field

        A moving exploration of the life and work of the celebrated American writer, blending biography and memoir with literary criticism. Since James Baldwin's death in 1987, his writing - including The Fire Next Time, one of the manifestoes of the Civil Rights Movement, and Giovanni's Room, a pioneering work of gay fiction - has only grown in relevance. Douglas Field was introduced to Baldwin's essays and novels by his father, who witnessed the writer's debate with William F. Buckley at Cambridge University in 1965. In Walking in the dark, he embarks on a journey to unravel his life-long fascination and to understand why Baldwin continues to enthral us decades after his death. Tracing Baldwin's footsteps in France, the US and Switzerland, and digging into archives, Field paints an intimate portrait of the writer's life and influence. At the same time, he offers a poignant account of coming to terms with his father's Alzheimer's disease. Interweaving Baldwin's writings on family, illness, memory and place, Walking in the dark is an eloquent testament to the enduring power of great literature to illuminate our paths.

      • Medicine
        1987

        Alzheimer Disease & Associated Disorders

        An International Journal

        by Edited by Charles DeCarli MD

        Quarterly - 2013 Volume(s) - 25 www.alzheimerjournal.com Alzheimer Disease and Associated Disorders is a leading international forum for reports of new research findings and new approaches to diagnosis and treatment. Contributions fall within all relevant scientific fields and clinical specialties, including neurobiology, neurochemistry, molecular biology, neurology, neuropathology, neuropsychology, psychiatry, gerontology, and geriatrics. Rigorous peer review of articles is ensured by an international Editorial Advisory Board of eminent scientists and clinicians.

      • Adventure stories (Children's/YA)
        November 2018

        CAPTAIN ZHEIMER

        by NACHO GOLFE

        What would you be willing to do for your grandparents? Discover this adventure through the ages. This crazy gang of friends will fight with dinosaurs, gladiators and above all, against ALZHEIMER. Fun, friendship, imagination and family. The story of a new Superhero. The story of a grandson and his grandfather.

      • Neurology & clinical neurophysiology
        April 2012

        Alzheimer's Diagnostic Guideline Validation

        Exploration of Next Steps: Workshop Summary

        by Diana E. Pankevich, Theresa Wizemann, and Bruce M. Altevogt, Rapporteurs; Forum on Neuroscience and Nervous Systems Disorders; Board on Health Sciences Policy; Institute of Medicine

        Scientific advances during the last decade now indicate that Alzheimer's disease is a continuous, progressive cognitive disease, most likely beginning many years before dementia is apparent. To discuss the next steps in validating new diagnostic guidelines for Alzheimer's disease, the IOM Forum on Neuroscience and Nervous System Disorders hosted a public workshop session at the Alzheimer's Association International Conference.

      • Diseases & disorders
        January 2011

        Future Opportunities to Leverage the Alzheimer's Disease Neuroimaging Initiative

        Workshop Summary

        by Theresa Wizemann, Diana E. Pankevich, and Bruce M. Altevogt, Rapporteurs; Forum on Neuroscience and Nervous System Disorders; Institute of Medicine

        Nearly 5.3 million Americans are living with Alzheimer's disease, and 26.6 million people are affected worldwide. The Alzheimer's Disease Neuroimaging Initiative (ADNI), a public-private partnership, provides a publicly available, international database of clinical and imaging data to foster research and collaboration on Alzheimer's research worldwide. The Institute of Medicine held a workshop on July 12, 2010, to explore opportunities to use information from and partnerships formed because of ADNI to continue to improve the understanding and treatment of Alzheimer's disease.

      • Volver

        by Valentina Iriarte

        "En casa. En cualquier lugar. No hay nada más que lo cotidiano, lo mínimo, la rutina. Lo que sucede todos los días, sin embargo, es una forma de recordar". Este libro álbum retrata sutilmente el encuentro entre dos ancianos que se encuentran cada día en un asilo de ancianos, que trata el tema del Alzheimer y la experiencia que tiene la gente cuando empieza de cero todos los días. Este álbum, no lo publiques todavía. pero su ISBN está listo.  formato A4   Libro Album que aún no ha sido impreso, trata del Alzheimer, esta dirigido a crear empatía a los cuidadores de las personas que padecen Demencia Senil.

      • Is it Alzheimer's?

        101 Answers to Your Most Pressing Questions about Memory Loss and Dementia

        by Peter Rabins, MD

        Dr. Rabins is coauthor of The 36-Hour Day. He has long been active in the field of dementia and Alzheimer research and education. The book features his answers to the questions that audiences most often ask him about Alzheimer disease and dementia. The questions are organized into seven sections (progressing from basics about memory loss and aging to more complex topics about caregiving and ethical dilemmas).

      • Diseases & disorders
        February 2016

        Assessing the Impact of Applications of Digital Health Records on Alzheimer's Disease Research

        Workshop Summary

        by Lisa Bain and Sheena Posey Norris, Rapporteurs; Forum on Neuroscience and Nervous System Disorders; Board on Health Sciences Policy; Institute of Medicine; National Academies of Sciences, Engineering, and Medicine

        Health information technology is providing patients, clinicians, and researchers with access to data that will enable novel approaches to science and medicine. Digital health records (DHRs) are capable of being shared across different health care settings for the examination of possible trends and long-term changes in a patient's disease progression or status as well as the effectiveness of the health care delivery system. While prevalence of paper records remains high, there has been a rapid trend toward the digitalization of medical and health records in many countries. DHRs are widely viewed as essential for improving health, reducing medical errors, and lowering costs. However, given that these databases have the potential to house the complete medical and health information of individuals, the potential misuse, de-identification or breaching of this data may have serious implications. On July 20, 2015, the Institute of Medicine's Forum on Neuroscience and Nervous System Disorders held a public session at the 2015 Alzheimer's Association International Conference to assess the impact of DHRs on Alzheimer's disease (AD) research. An estimated 46.8 million people worldwide are currently living with dementia, and the prevalence is expected to double every year for the next 20 years. Given the few therapies currently available to treat the symptoms of AD, compared to other central nervous system disorders, participants explored how DHRs may be used to help improve clinical trial design and methodology for AD research. This report summarizes the presentations and discussions from this workshop.

      Subscribe to our

      newsletter